Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9357 |
High Similarity |
NPD1549 |
Phase 2 |
0.9286 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.9286 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9236 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.9143 |
High Similarity |
NPD1510 |
Phase 2 |
0.9078 |
High Similarity |
NPD2796 |
Approved |
0.9067 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD1240 |
Approved |
0.8933 |
High Similarity |
NPD1934 |
Approved |
0.8926 |
High Similarity |
NPD4380 |
Phase 2 |
0.8874 |
High Similarity |
NPD7819 |
Suspended |
0.8867 |
High Similarity |
NPD7411 |
Suspended |
0.8865 |
High Similarity |
NPD1607 |
Approved |
0.8844 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8824 |
High Similarity |
NPD7075 |
Discontinued |
0.8824 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD2801 |
Approved |
0.875 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8649 |
High Similarity |
NPD6799 |
Approved |
0.8649 |
High Similarity |
NPD1511 |
Approved |
0.8636 |
High Similarity |
NPD3882 |
Suspended |
0.8608 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.859 |
High Similarity |
NPD5494 |
Approved |
0.8581 |
High Similarity |
NPD3749 |
Approved |
0.8571 |
High Similarity |
NPD3750 |
Approved |
0.8553 |
High Similarity |
NPD6599 |
Discontinued |
0.8535 |
High Similarity |
NPD6959 |
Discontinued |
0.8533 |
High Similarity |
NPD1512 |
Approved |
0.8516 |
High Similarity |
NPD7768 |
Phase 2 |
0.8503 |
High Similarity |
NPD2800 |
Approved |
0.8491 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8491 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8491 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8442 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8435 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8397 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8385 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8378 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8367 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8356 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.831 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8282 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8235 |
Intermediate Similarity |
NPD920 |
Approved |
0.8231 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8224 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8224 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8224 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8221 |
Intermediate Similarity |
NPD7054 |
Approved |
0.821 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8201 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.82 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8176 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8176 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8176 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8146 |
Intermediate Similarity |
NPD2309 |
Approved |
0.8137 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8133 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8121 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.8117 |
Intermediate Similarity |
NPD5403 |
Approved |
0.811 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.8105 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8095 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8079 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8072 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8072 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8071 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.8069 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8042 |
Intermediate Similarity |
NPD2798 |
Approved |
0.8024 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8024 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8013 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7974 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7972 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7961 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD943 |
Approved |
0.7945 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7931 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7925 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7904 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7874 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7847 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7799 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7786 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7762 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7756 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7692 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7667 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7667 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7639 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7639 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7632 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7627 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7627 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD919 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7603 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7603 |
Intermediate Similarity |
NPD3266 |
Approved |
0.76 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD1613 |
Approved |
0.759 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7584 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7569 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7568 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7558 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.755 |
Intermediate Similarity |
NPD447 |
Suspended |
0.755 |
Intermediate Similarity |
NPD1933 |
Approved |
0.755 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7548 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7547 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7546 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7546 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7543 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7535 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7531 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7467 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7434 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD17 |
Approved |
0.7429 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD6279 |
Approved |
0.7423 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7419 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7394 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7389 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7368 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD411 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7317 |
Intermediate Similarity |
NPD37 |
Approved |
0.7312 |
Intermediate Similarity |
NPD7584 |
Approved |
0.731 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7289 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7285 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7268 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7261 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7256 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3140 |
Approved |
0.725 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7247
|
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |